Haemonetics Corp. buy BTIG Research
Start price
09.01.26
/
50%
€72.00
Target price
09.01.27
€75.54
Performance (%)
-22.22%
Price
02.02.26
€56.00
Summary
This prediction is currently active. The price of Haemonetics Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -22.22%. This prediction currently runs until 09.01.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Haemonetics Corp. | -3.419% |
| iShares Core DAX® | -1.553% |
| iShares Nasdaq 100 | -0.386% |
| iShares Nikkei 225® | 1.640% |
| iShares S&P 500 | 0.114% |
Comments by BTIG_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€67.50
21.11.25
21.11.25
€76.29
21.11.26
21.11.26
-17.04%
02.02.26
02.02.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.50
06.11.25
06.11.25
€76.46
06.11.26
06.11.26
-2.61%
02.02.26
02.02.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.50
10.09.24
10.09.24
€101.52
10.09.25
10.09.25
-32.03%
11.09.25
11.09.25